SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Hatshepsut

PatientHatshepsut
Date of birth1978-02-10
IdentifiersMRN HR-AC006-SYN; SSN (made up) 000-06-9440
Document date2026-07-21
AuthorAmunet Okafor-Harrington, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Fourteen-week review: A1c, lipids, weight, periodontal therapy, knees, and screening results. [S]

History of Present Illness

Ms. Hatshepsut returns fourteen weeks after diabetes was found. She has taken semaglutide 0.5 mg weekly for three weeks, with mild fullness after large meals and no vomiting, with metformin 1000 mg and atorvastatin 20 mg each evening. She finished scaling and root planing six weeks ago; her gums bleed less. Her screening mammogram last week was normal, and the HPV test, the fecal immunochemical test, and the HIV and hepatitis tests were negative. She walks about 120 minutes a week and climbs the stairs at the sites with less knee pain. [S]

ElementDetail
MedicinesSemaglutide 0.5 mg weekly, metformin 1000 mg, atorvastatin 20 mg
GumsScaling and root planing completed; bleeding less
ScreeningMammogram normal; HPV, FIT, HIV and hepatitis tests negative

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy good; weight falling slowly
GastrointestinalPositiveMild fullness after large meals; no vomiting or abdominal pain
MusculoskeletalPositiveKnee pain on stairs, much less than before; no muscle aches on the statin
PsychiatricNegativeMood good

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ibuprofen 400 mg oral tablet, one tablet by mouth every six hours as needed for dental pain, with food, for up to one weekOne tablet every six hours as needed, with food; no more than four a dayOral route2026-04-14 to 2026-04-22completedS
Acetaminophen 500 mg oral tablet, two tablets (1 g) by mouth every six hours as needed for dental pain, alternating with ibuprofen, no more than 3 g a day, for up to one weekTwo tablets every six hours as needed; no more than six a dayOral route2026-04-14 to 2026-04-22completedS
Metformin extended-release 500 mg tablet, one tablet with the evening meal for one week, then two tablets (1000 mg) with the evening mealOne tablet with the evening meal for a week, then twoOral route2026-04-14activeS
Diclofenac sodium 1% gel, 4 g to each painful knee up to four times a day as needed4 g to each knee up to four times a day as neededTopical route2026-04-14activeS
Chlorhexidine gluconate 0.12% oral rinse, 15 mL swished for 30 seconds and spat out twice daily for two weeks after the extraction15 mL rinse twice daily for two weeksOral route2026-04-15 to 2026-04-29completedS
Semaglutide 0.25 mg subcutaneous injection once weekly (starting dose, planned for four weeks)0.25 mg once weeklySubcutaneous route2026-05-26 to 2026-06-30completedS
Semaglutide 0.5 mg subcutaneous injection once weekly (maintenance dose for now)0.5 mg once weeklySubcutaneous route2026-06-30activeS
Atorvastatin 20 mg oral tablet, one tablet by mouth dailyOne tablet dailyOral route2026-05-26activeS
Nitrofurantoin monohydrate/macrocrystals 100 mg capsule, one capsule by mouth twice daily with food for five daysOne capsule twice daily with food for five daysOral route2026-06-23 to 2026-06-28completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-07-21Body height160cmS
2026-07-21Body weight88.6kgS
2026-07-21Body mass index (BMI) [Ratio]34.6kg/m2S
2026-07-21Systolic blood pressure120mm[Hg]S
2026-07-21Diastolic blood pressure76mm[Hg]S
2026-07-21Heart rate74/minS
2026-07-21Respiratory rate14/minS
2026-07-21Body temperature36.6CelS
2026-07-21Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-21Hemoglobin A1c/Hemoglobin.total in Blood6.6%Below 5.7% is normal; 6.5% or more is diabetes; goal below 7% for most adults with diabetesHighS
2026-07-21Cholesterol [Mass/volume] in Serum or Plasma152mg/dL<=199 mg/dLNormalS
2026-07-21Cholesterol in HDL [Mass/volume] in Serum or Plasma48mg/dL>=50 mg/dLLowS
2026-07-21Triglyceride [Mass/volume] in Serum or Plasma140mg/dL<=149 mg/dLNormalS
2026-07-21Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation76mg/dLGoal below 100 mg/dL in diabetes, below 70 mg/dL at higher riskNormalS
2026-07-21Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma27U/L7-35 U/LNormalS
2026-07-21Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S

Physical Exam

Vital signs recorded on 2026-07-21; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 88.6 kg, BMI 34.6; blood pressure 120/76, pulse 74
MouthGums pinker, less calculus
KneesCrepitus; no effusion

Problems

ProblemClinical statusVerificationCodeProvenance
Painful swelling of the left lower jaw for four days, after a throbbing toothache for three weeks under a broken lower left molar; low-grade temperature, no trismus, no swelling of the floor of the mouth or neck; dental abscess suspectedresolvedconfirmed R68.84S — Synthetic presenting concern at the index visit, superseded by the dental diagnosis the next day. It echoes the dental disease reported on the mummy identified as hers (R, after the index date), without linking to it.
Acute periapical abscess of the lower left first molar (tooth 19), non-restorable, with a localized buccal vestibular swelling and no spread to fascial spaces; drained and extractedresolvedconfirmed K04.7S — Synthetic modern diagnosis; no historical claim is made.
Type 2 diabetes found on screening (hemoglobin A1c 7.6% with a random glucose of 212 mg/dL from the same sample), with thirst and waking at night to pass urine; normal kidney function and urine albuminactiveconfirmed E11.65S — Synthetic screening finding at intake; not linked to the disputed claim of diabetes on the mummy (R).
Obesity, class 2 (BMI 36.3), with type 2 diabetes and knee osteoarthritis; she wants to feel stronger and move more easilyactiveconfirmed E66.812S — Synthetic finding at intake, recorded in person-first language.
Primary osteoarthritis of both knees: pain on stairs and after standing, morning stiffness under 30 minutes, crepitus, no effusion; a clinical diagnosis without imagingactiveconfirmed M17.0S — Synthetic finding at intake; not linked to the osteoarthritis reported on the mummy (R).
Periodontitis, generalized, stage III, grade C (bone loss to the middle third of the roots, two molars lost earlier to gum disease, and A1c above 7% as a grade modifier)activeconfirmed K05.323S — Synthetic finding at the dental consultation.
Acute uncomplicated cystitis (dysuria and frequency for two days, urine dipstick positive for leukocyte esterase and nitrite, no fever or flank pain); urine culture grew Escherichia coli sensitive to nitrofurantoin; resolvedresolvedconfirmed N30.00S — Synthetic intercurrent illness; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryHemoglobin A1cEvery three months until at goal or after a change in therapy, then every six monthsCompleted today6.6%, down from 7.6%
ExaminationBlood pressure (goal below 130/80)Every visitCompleted today120/76
ExaminationWeight and BMI, recorded with her permissionEvery visitCompleted today88.6 kg, BMI 34.6; down 5% since intake
Medication safetyMetformin: dose, tolerance and sick-day rulesEvery visitCompleted today1000 mg tolerated
Medication safetyGLP-1 receptor agonist: dose, nausea, warning signsEvery visitCompleted today0.5 mg for three weeks; mild fullness only; no pancreatitis or gallbladder symptoms
LaboratoryLipid panel and ALT on a statin4 to 12 weeks after starting a statin, then yearlyCompleted todayLDL 76 mg/dL, HDL 48, triglycerides 140, total 152; ALT 27 U/L
LaboratoryUrine albumin-to-creatinine ratio and eGFRYearlyUp to dateNormal at intake; next in nine months
ExaminationComprehensive foot examinationYearlyUp to dateNormal at the six-week visit
ImagingDiabetic eye screeningEvery one to two years without retinopathyUp to dateNo retinopathy at the six-week visit
SurveyDepression screen (PHQ-9)At diagnosis and at least yearlyCompleted todayPHQ-9 2
SurveyDiabetes distress screenAt diagnosis and at least yearlyDeferredMissed: the CMID diabetes monograph calls for a diabetes distress screen at diagnosis and yearly, and none was done at intake or since. Judging by her low PHQ-9 and GAD-7 scores and her engagement, no harm resulted. Corrective action: a two-item diabetes distress screen at the next visit, added to the diabetes visit template
Self-managementDiabetes self-management education and nutrition therapyAt diagnosis, then yearlyCompleted todayAll four sessions completed
ExaminationDental and periodontal carePeriodontal maintenance every three monthsCompleted todayScaling and root planing completed six weeks ago; maintenance booked
ExaminationKnee pain and functionEvery visitCompleted todayLess pain on stairs
Medication safetyHepatitis B vaccine, dose 2At least four weeks after dose 1DueDose 1 three weeks ago; dose 2 at a nurse visit next week

Goal progress:

Guideline basis: Standards of Care in Diabetes—2026 (Section 2, Diagnosis and Classification of Diabetes; Section 9, Pharmacologic Approaches to Glycemic Treatment) (2026); Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes—2026 (Section 8) (2026); Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (Section 10) (2026); Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology (2018); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); Depression and Suicide Risk in Adults: Screening (2023); CMID: Clinical Monitoring Intelligence Database, diabetes type 2, rheumatoid arthritis and osteoarthritis, and hyperlipidemia monographs (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Review in three months with A1c; periodontal maintenance every three months; second hepatitis B dose next week; influenza and COVID-19 vaccines in the autumn; next preventive visit in one year. [S]